Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Top Cited Papers
- 12 October 2006
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (15) , 1525-1538
- https://doi.org/10.1056/nejmoa061240
Abstract
Second-generation (atypical) antipsychotic drugs are widely used to treat psychosis, aggression, and agitation in patients with Alzheimer's disease, but their benefits are uncertain and concerns about safety have emerged. We assessed the effectiveness of atypical antipsychotic drugs in outpatients with Alzheimer's disease.Keywords
This publication has 25 references indexed in Scilit:
- Old and Ill and Still Feeling Well? Determinants of Subjective Well-Being in ≥60 Year Olds: The Role of the Sense of CoherenceAmerican Journal of Geriatric Psychiatry, 2006
- Risk of Death With Atypical Antipsychotic Drug Treatment for DementiaJAMA, 2005
- Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trialsCMAJ : Canadian Medical Association Journal, 2004
- Depression in Alzheimer’s disease: overview and treatmentBiological Psychiatry, 2002
- Psychosis of Alzheimer's Disease and Related Dementias: Diagnostic Criteria for a Distinct SyndromeAmerican Journal of Geriatric Psychiatry, 2000
- Incidence of and risk factors for hallucinations and delusions in patients with probable ADNeurology, 2000
- Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older PatientsJournal of the American Geriatrics Society, 1999
- The Course of Psychopathologic Features in Mild to Moderate Alzheimer DiseaseArchives of General Psychiatry, 1997
- Anticonvulsant and Other Non-neuroleptic Treatment of Agitation in DementiaJournal of Geriatric Psychiatry and Neurology, 1995
- A Metaanalysis of Controlled Trials of Neuroleptic Treatment in DementiaJournal of the American Geriatrics Society, 1990